Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation
- PMID: 39303730
- DOI: 10.1016/S2542-5196(24)00230-4
Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation
Conflict of interest statement
AB declares receiving payment for giving a lecture on planetary health at the University of Edinburgh (Edinburgh, UK), support for attending a PlanED Prescribing meeting by Erasmus+, and support for attending a meeting on climate and health and green clinical trials by the British Academy of Medical Sciences. CTAM declares receiving funding for the TransPharm Project, which deals with sustainable pharmaceuticals and aims to provide a methodology for sustainability assessment, by Horizon Europe. All other authors declare no competing interests. This Comment was authored by the consortium of the Erasmus+ project Planetary Health Education in Prescribing. This project, and therefore this Comment, is funded by the EU under Erasmus+ grant 2023-1-NL01-KA220-HED-000166537. During the preparation of this Comment, the authors used ChatGPT in the writing process to improve readability and language (prompt: improve writing/grammar). No content was generated by ChatGPT. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.
MeSH terms
LinkOut - more resources
Full Text Sources